How much is TRIANA Biomedicines worth in 2026?

TRIANA Biomedicines has a current valuation of $258.0M based on their Later Stage VC round and secondary market data.

How much funding has TRIANA Biomedicines raised?

TRIANA Biomedicines has raised $246.1M in total funding across 2 funding rounds.

TRIANA Biomedicines

Discovery Tools (Healthcare)Website

TRIANA Biomedicines valuation and funding history | Last updated: December 3, 2025 | 2 funding rounds

Current Valuation

$258.0M

As of December 3, 2025

Total Funding Raised

$246.1M

Across 2 rounds

Last Round

Later Stage VC

$120.1M

Last Funding

Dec 2025

Funding date

Capital Efficiency

1.05x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
November 26, 2025	Later Stage VC (Series B)	$120.1M	N/A	-
April 20, 2022	Early Stage VC (Series A)	$110.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

TRIANA Biomedicines is currently valued at $258.0M as of December 3, 2025. The company has raised a total of $246.1M in funding across 2 funding rounds.

Capital Efficiency

With a capital efficiency ratio of 1.05x, TRIANA Biomedicines has achieved a valuation that is 1.05 times the total capital raised.

Track TRIANA Biomedicines Valuation Updates

Get notified when TRIANA Biomedicines raises new funding or valuation changes

Explore More Data

Detailed analysis for TRIANA Biomedicines

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock TRIANA Biomedicines's valuation history, funding rounds, and growth metrics.

No credit card required

What is TRIANA Biomedicines Worth in 2026?

TRIANA Biomedicines is a leading private company in the Discovery Tools (Healthcare) sector. Track TRIANA Biomedicines's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How TRIANA Biomedicines Valuation is Determined

Private company valuations like TRIANA Biomedicines's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.